TrialThe Lancet. Microbe2022

Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent

William Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.